{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:22:06Z","timestamp":1793733726780,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["754513"],"award-info":[{"award-number":["754513"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R250-2017-1131"],"award-info":[{"award-number":["R250-2017-1131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["DANDRITE-R248-2016-2518"],"award-info":[{"award-number":["DANDRITE-R248-2016-2518"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R171-2014-591"],"award-info":[{"award-number":["R171-2014-591"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["703205"],"award-info":[{"award-number":["703205"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-153199"],"award-info":[{"award-number":["PJT-153199"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0554-9","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T03:57:15Z","timestamp":1530244635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-0070","authenticated-orcid":false,"given":"Asad","family":"Jan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Jansonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Delaidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forum","family":"Bhanshali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Andy","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens C.","family":"Schwamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul H.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul H.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","volume":"36","author":"M Ahuja","year":"2016","unstructured":"Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour-Djebbar I et al (2016) Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci 36:6332\u20136351. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0426-16.2016","journal-title":"J Neurosci"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329752. \n                    https:\/\/doi.org\/10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.stemcr.2017.08.026","volume":"9","author":"J Arias-Fuenzalida","year":"2017","unstructured":"Arias-Fuenzalida J, Jarazo J, Qing X, Walter J, Gomez-Giro G, Nickels SL, Zaehres H, Scholer HR, Schwamborn JC (2017) FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson's disease modeling. Stem Cell Rep 9:1423\u20131431. \n                    https:\/\/doi.org\/10.1016\/j.stemcr.2017.08.026","journal-title":"Stem Cell Rep"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0301-0082(95)00009-K","volume":"46","author":"MM Behbehani","year":"1995","unstructured":"Behbehani MM (1995) Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46:575\u2013605","journal-title":"Prog Neurobiol"},{"issue":"Suppl 1","key":"554_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson's disease. J Neurochem 139(Suppl 1):216\u2013231. \n                    https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.cdd.4402296","volume":"15","author":"M Boyce","year":"2008","unstructured":"Boyce M, Py BF, Ryazanov AG, Minden JS, Long K, Ma D, Yuan J (2008) A pharmacoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death. Cell Death Differ 15:589\u2013599. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4402296","journal-title":"Cell Death Differ"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486:235\u2013239. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2010.09.061","journal-title":"Neurosci Lett"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbrc.2009.11.022","volume":"391","author":"JS Choi","year":"2010","unstructured":"Choi JS, Park C, Jeong JW (2010) AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Biochem Biophys Res Commun 391:147\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.022","journal-title":"Biochem Biophys Res Commun"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.devcel.2014.01.027","volume":"28","author":"HP Chu","year":"2014","unstructured":"Chu HP, Liao Y, Novak JS, Hu Z, Merkin JJ, Shymkiv Y, Braeckman BP, Dorovkov MV, Nguyen A, Clifford PM et al (2014) Germline quality control: eEF2K stands guard to eliminate defective oocytes. Dev Cell 28:561\u2013572. \n                    https:\/\/doi.org\/10.1016\/j.devcel.2014.01.027","journal-title":"Dev Cell"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrn2867","volume":"11","author":"GL Collingridge","year":"2010","unstructured":"Collingridge GL, Peineau S, Howland JG, Wang YT (2010) Long-term depression in the CNS. Nat Rev Neurosci 11:459\u2013473. \n                    https:\/\/doi.org\/10.1038\/nrn2867","journal-title":"Nat Rev Neurosci"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/npjparkd.2015.22","volume":"1","author":"JF Cooper","year":"2015","unstructured":"Cooper JF, Dues DJ, Spielbauer KK, Machiela E, Senchuk MM, Van Raamsdonk JM (2015) Delaying aging is neuroprotective in Parkinson's disease: a genetic analysis in C. Elegans models. NPJ Parkinsons Dis 1:15022. \n                    https:\/\/doi.org\/10.1038\/npjparkd.2015.22","journal-title":"NPJ Parkinsons Dis"},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"16441","DOI":"10.1038\/s41598-017-16637-2","volume":"7","author":"JF Cooper","year":"2017","unstructured":"Cooper JF, Machiela E, Dues DJ, Spielbauer KK, Senchuk MM, Van Raamsdonk JM (2017) Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson's disease models. Sci Rep 7:16441. \n                    https:\/\/doi.org\/10.1038\/s41598-017-16637-2\n                    \n                   10.1038\/s41598-017-16637-2","journal-title":"Sci Rep"},{"key":"554_CR14","first-page":"32046","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. JBiolChem 277:32046\u201332053","journal-title":"JBiolChem"},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/15384101.2016.1254974","volume":"16","author":"A De Gassart","year":"2017","unstructured":"De Gassart A, Martinon F (2017) Translating the anticancer properties of eEF2K. Cell Cycle 16:299\u2013300. \n                    https:\/\/doi.org\/10.1080\/15384101.2016.1254974","journal-title":"Cell Cycle"},{"key":"554_CR16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/cdd.2017.79","volume":"24","author":"A Delaidelli","year":"2017","unstructured":"Delaidelli A, Negri GL, Jan A, Jansonius B, El-Naggar A, Lim JKM, Khan D, Zarni Oo H, Carnie CJ, Remke M et al (2017) MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation. Cell Death Differ 24:1564\u20131576. \n                    https:\/\/doi.org\/10.1038\/cdd.2017.79","journal-title":"Cell Death Differ"},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-43589-3_7","volume":"107","author":"M Domise","year":"2016","unstructured":"Domise M, Vingtdeux V (2016) AMPK in neurodegenerative diseases. EXS 107:153\u2013177. \n                    https:\/\/doi.org\/10.1007\/978-3-319-43589-3_7","journal-title":"EXS"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty S, Jenner P (2011) Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164:1357\u20131391. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01426.x","journal-title":"Br J Pharmacol"},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40478-015-0257-4","volume":"3","author":"P Garcia-Esparcia","year":"2015","unstructured":"Garcia-Esparcia P, Hernandez-Ortega K, Koneti A, Gil L, Delgado-Morales R, Castano E, Carmona M, Ferrer I (2015) Altered machinery of protein synthesis is region- and stage-dependent and is associated with alpha-synuclein oligomers in Parkinson's disease. Acta Neuropathol Commun 3:76. \n                    https:\/\/doi.org\/10.1186\/s40478-015-0257-4\n                    \n                   10.1186\/s40478-015-0257-4","journal-title":"Acta Neuropathol Commun"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW (1995) Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease. Ann Neurol 37:714\u2013722. \n                    https:\/\/doi.org\/10.1002\/ana.410370604","journal-title":"Ann Neurol"},{"key":"554_CR22","doi-asserted-by":"publisher","unstructured":"Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG (2015) A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. J Vis Exp. \n                    https:\/\/doi.org\/10.3791\/53257","DOI":"10.3791\/53257"},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fncel.2014.00035","volume":"8","author":"C Heise","year":"2014","unstructured":"Heise C, Gardoni F, Culotta L, di Luca M, Verpelli C, Sala C (2014) Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons. Front Cell Neurosci 8:35. \n                    https:\/\/doi.org\/10.3389\/fncel.2014.00035","journal-title":"Front Cell Neurosci"},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1523\/JNEUROSCI.1569-03.2004","volume":"24","author":"T Hills","year":"2004","unstructured":"Hills T, Brockie PJ, Maricq AV (2004) Dopamine and glutamate control area-restricted search behavior in Caenorhabditis elegans. J Neurosci 24:1217\u20131225. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1569-03.2004\n                    \n                   24\/5\/1217","journal-title":"J Neurosci"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1242\/bio.20134853","volume":"2","author":"KM Holmstrom","year":"2013","unstructured":"Holmstrom KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM, Stanyer L, Yamamoto M, Dinkova-Kostova AT, Abramov AY (2013) Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2:761\u2013770. \n                    https:\/\/doi.org\/10.1242\/bio.20134853\n                    \n                   BIO20134853","journal-title":"Biol Open"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cotox.2016.10.002","volume":"1","author":"KM Holmstrom","year":"2016","unstructured":"Holmstrom KM, Kostov RV, Dinkova-Kostova AT (2016) The multifaceted role of Nrf2 in mitochondrial function. Curr Opin Toxicol 1:80\u201391. \n                    https:\/\/doi.org\/10.1016\/j.cotox.2016.10.002%20S2468-2020(16)30025-0","journal-title":"Curr Opin Toxicol"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401\u2013410","journal-title":"Am J Pathol"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-016-1634-1","volume":"133","author":"A Jan","year":"2017","unstructured":"Jan A, Jansonius B, Delaidelli A, Somasekharan SP, Bhanshali F, Vandal M, Negri GL, Moerman D, MacKenzie I, Calon F et al (2017) eEF2K inhibition blocks Abeta42 neurotoxicity by promoting an NRF2 antioxidant response. Acta Neuropathol 133:101\u2013119. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1634-1","journal-title":"Acta Neuropathol"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","volume":"169","author":"B Janetzky","year":"1994","unstructured":"Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, Zochling R, Boissl KW, Reichmann H (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 169:126\u2013128","journal-title":"Neurosci Lett"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.neurobiolaging.2012.11.001","volume":"34","author":"P Jiang","year":"2013","unstructured":"Jiang P, Gan M, Ebrahim AS, Castanedes-Casey M, Dickson DW, Yen SH (2013) Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of alpha-synuclein oligomers and decrease of neurites. Neurobiol Aging 34:1504\u20131515. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.11.001","journal-title":"Neurobiol Aging"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","volume":"88","author":"DA Johnson","year":"2015","unstructured":"Johnson DA, Johnson JA (2015) Nrf2--a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88:253\u2013267. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.07.147","journal-title":"Free Radic Biol Med"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","volume":"320","author":"E Junn","year":"2002","unstructured":"Junn E, Mouradian MM (2002) Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320:146\u2013150","journal-title":"Neurosci Lett"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson's disease. Lancet 386:896\u2013912. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","volume":"55","author":"JW Kenney","year":"2014","unstructured":"Kenney JW, Moore CE, Wang X, Proud CG (2014) Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. Adv Biol Regul 55:15\u201327. \n                    https:\/\/doi.org\/10.1016\/j.jbior.2014.04.003","journal-title":"Adv Biol Regul"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1523\/JNEUROSCI.2866-14.2015","volume":"35","author":"JW Kenney","year":"2015","unstructured":"Kenney JW, Sorokina O, Genheden M, Sorokin A, Armstrong JD, Proud CG (2015) Dynamics of elongation factor 2 kinase regulation in cortical neurons in response to synaptic activity. J Neurosci 35:3034\u20133047. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2866-14.2015","journal-title":"J Neurosci"},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1038\/cddis.2013.447","volume":"4","author":"TW Kim","year":"2013","unstructured":"Kim TW, Cho HM, Choi SY, Suguira Y, Hayasaka T, Setou M, Koh HC, Hwang EM, Park JY, Kang SJ et al (2013) (ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's disease. Cell Death Dis 4:e919. \n                    https:\/\/doi.org\/10.1038\/cddis.2013.447","journal-title":"Cell Death Dis"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-0270(87)90041-0","volume":"20","author":"JY Koh","year":"1987","unstructured":"Koh JY, Choi DW (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83\u201390","journal-title":"J Neurosci Methods"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CPAA.S12082 cpaa-2-185","volume":"2","author":"R Kones","year":"2010","unstructured":"Kones R (2010) Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying. Clin Pharmacol 2:185\u2013198. \n                    https:\/\/doi.org\/10.2147\/CPAA.S12082\n                    \n                   cpaa-2-185","journal-title":"Clin Pharmacol"},{"key":"554_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348. \n                    https:\/\/doi.org\/10.1038\/nrn3406","journal-title":"Nat Rev Neurosci"},{"key":"554_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1601-183X.2009.00513.x","volume":"8","author":"J Lee","year":"2009","unstructured":"Lee J, Jee C, McIntire SL (2009) Ethanol preference in C. Elegans. Genes Brain Behav 8:578\u2013585. \n                    https:\/\/doi.org\/10.1111\/j.1601-183X.2009.00513.x","journal-title":"Genes Brain Behav"},{"key":"554_CR41","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 99:8968\u20138973. \n                    https:\/\/doi.org\/10.1073\/pnas.132197599\n                    \n                   99\/13\/8968","journal-title":"Proc Natl Acad Sci U S A"},{"key":"554_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","volume":"153","author":"G Leprivier","year":"2013","unstructured":"Leprivier G, Remke M, Rotblat B, Dubuc A, Mateo AR, Kool M, Agnihotri S, El-Naggar A, Yu B, Somasekharan SP et al (2013) The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153:1064\u20131079. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.04.055","journal-title":"Cell"},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","volume":"272","author":"X Li","year":"2005","unstructured":"Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J 272:4211\u20134220. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2005.04833.x","journal-title":"FEBS J"},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. \n                    https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1042\/BJ20130863","volume":"457","author":"MH Ludtmann","year":"2014","unstructured":"Ludtmann MH, Angelova PR, Zhang Y, Abramov AY, Dinkova-Kostova AT (2014) Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem J 457:415\u2013424. \n                    https:\/\/doi.org\/10.1042\/BJ20130863","journal-title":"Biochem J"},{"key":"554_CR46","doi-asserted-by":"publisher","first-page":"12230","DOI":"10.1523\/JNEUROSCI.1694-14.2014","volume":"34","author":"T Ma","year":"2014","unstructured":"Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E (2014) Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid beta. J Neurosci 34:12230\u201312238. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1694-14.2014","journal-title":"J Neurosci"},{"key":"554_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mito.2016.05.003","volume":"29","author":"AN Malik","year":"2016","unstructured":"Malik AN, Czajka A, Cunningham P (2016) Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences. Mitochondrion 29:59\u201364. \n                    https:\/\/doi.org\/10.1016\/j.mito.2016.05.003","journal-title":"Mitochondrion"},{"key":"554_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22:66\u201379. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2012.05.016","journal-title":"Cancer Cell"},{"key":"554_CR49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel AS, Smits LM, Hemmer K, Hachi S, Moreno EL, van Wuellen T, Jarazo J, Walter J, Bruggemann I, Boussaad I et al (2017) Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Reports 8:1144\u20131154. \n                    https:\/\/doi.org\/10.1016\/j.stemcr.2017.03.010","journal-title":"Stem Cell Reports"},{"key":"554_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev.pharmtox.43.100901.135934","volume":"43","author":"R Nass","year":"2003","unstructured":"Nass R, Blakely RD (2003) The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu Rev Pharmacol Toxicol 43:521\u2013544. \n                    https:\/\/doi.org\/10.1146\/annurev.pharmtox.43.100901.135934\n                    \n                   100901.135934","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"554_CR51","doi-asserted-by":"publisher","first-page":"14311","DOI":"10.1523\/JNEUROSCI.0499-12.2012","volume":"32","author":"CH Ng","year":"2012","unstructured":"Ng CH, Guan MS, Koh C, Ouyang X, Yu F, Tan EK, O'Neill SP, Zhang X, Chung J, Lim KL (2012) AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease. J Neurosci 32:14311\u201314317. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0499-12.2012","journal-title":"J Neurosci"},{"key":"554_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00000372-199808000-00006","volume":"20","author":"GE Orchard","year":"1998","unstructured":"Orchard GE, Calonje E (1998) The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms. Am J Dermatopathol 20:357\u2013361","journal-title":"Am J Dermatopathol"},{"key":"554_CR53","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"554_CR54","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"554_CR55","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"AK Reeve","year":"2015","unstructured":"Reeve AK, Ludtmann MH, Angelova PR, Simcox EM, Horrocks MH, Klenerman D, Gandhi S, Turnbull DM, Abramov AY (2015) Aggregated alpha-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6:e1820. \n                    https:\/\/doi.org\/10.1038\/cddis.2015.166","journal-title":"Cell Death Dis"},{"key":"554_CR56","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR, Nagar S, Talantova M et al (2013) Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155:1351\u20131364. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.11.009","journal-title":"Cell"},{"key":"554_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0014-5793(02)02299-8","volume":"514","author":"AG Ryazanov","year":"2002","unstructured":"Ryazanov AG (2002) Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett 514:26\u201329","journal-title":"FEBS Lett"},{"key":"554_CR58","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR et al (2014) Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 111:10732\u201310737. \n                    https:\/\/doi.org\/10.1073\/pnas.1321785111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"554_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7:97\u2013109. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(07)70327-7","journal-title":"Lancet Neurol"},{"key":"554_CR60","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269","journal-title":"Lancet"},{"key":"554_CR61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","volume":"25","author":"K Seidel","year":"2015","unstructured":"Seidel K, Mahlke J, Siswanto S, Kruger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW et al (2015) The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Brain Pathol 25:121\u2013135. \n                    https:\/\/doi.org\/10.1111\/bpa.12168","journal-title":"Brain Pathol"},{"key":"554_CR62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. \n                    https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"554_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneumeth.2009.11.004","volume":"186","author":"RG Tremblay","year":"2010","unstructured":"Tremblay RG, Sikorska M, Sandhu JK, Lanthier P, Ribecco-Lutkiewicz M, Bani-Yaghoub M (2010) Differentiation of mouse Neuro 2A cells into dopamine neurons. J Neurosci Methods 186:60\u201367. \n                    https:\/\/doi.org\/10.1016\/j.jneumeth.2009.11.004","journal-title":"J Neurosci Methods"},{"key":"554_CR64","doi-asserted-by":"publisher","first-page":"22940","DOI":"10.1038\/srep22940","volume":"6","author":"NF Trojanowski","year":"2016","unstructured":"Trojanowski NF, Raizen DM, Fang-Yen C (2016) Pharyngeal pumping in Caenorhabditis elegans depends on tonic and phasic signaling from the nervous system. Sci Rep 6:22940. \n                    https:\/\/doi.org\/10.1038\/srep22940","journal-title":"Sci Rep"},{"key":"554_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI (2016) Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:49\u201373. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1485-1\n                    \n                   10.1007\/s00401-015-1485-1","journal-title":"Acta Neuropathol"},{"key":"554_CR66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ et al (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 79:887\u2013902. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2013.06.036","journal-title":"Neuron"},{"key":"554_CR67","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","volume":"10","author":"K Vekrellis","year":"2011","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 10:1015\u20131025. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(11)70213-7","journal-title":"Lancet Neurol"},{"key":"554_CR68","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/hmg\/dds003","volume":"21","author":"X Wang","year":"2012","unstructured":"Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, Perry G, Casadesus G, Zhu X (2012) LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 21:1931\u20131944. \n                    https:\/\/doi.org\/10.1093\/hmg\/dds003","journal-title":"Hum Mol Genet"},{"key":"554_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.1986.0056","volume":"314","author":"JG White","year":"1986","unstructured":"White JG, Southgate E, Thomson JN, Brenner S (1986) The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond Ser B Biol Sci 314:1\u2013340","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"554_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/B978-0-12-384878-9.00015-7","volume":"100","author":"B Wolozin","year":"2011","unstructured":"Wolozin B, Gabel C, Ferree A, Guillily M, Ebata A (2011) Watching worms whither: modeling neurodegeneration in C. elegans. Prog Mol Biol Transl Sci 100:499\u2013514. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-384878-9.00015-7","journal-title":"Prog Mol Biol Transl Sci"},{"key":"554_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23:1\u201313. \n                    https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0554-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T15:46:36Z","timestamp":1569253596000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0554-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0554-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,2]]},"assertion":[{"value":"6 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AJ was formerly a Postdoctoral Fellow in the research laboratory of PHS at the University of British Columbia (Canada), and since October 2017 is affiliated with Aarhus University (Denmark) as AIAS-COFUND Junior Research Fellow.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}